nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—SLC12A1—appendage—amyotrophic lateral sclerosis	0.0608	0.106	CbGeAlD
Hydroflumethiazide—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0302	0.0965	CcSEcCtD
Hydroflumethiazide—CA1—nerve—amyotrophic lateral sclerosis	0.0297	0.0518	CbGeAlD
Hydroflumethiazide—KCNMA1—hindbrain—amyotrophic lateral sclerosis	0.0292	0.0511	CbGeAlD
Hydroflumethiazide—CA4—nerve—amyotrophic lateral sclerosis	0.0232	0.0405	CbGeAlD
Hydroflumethiazide—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.023	0.0734	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0202	0.0646	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0635	CcSEcCtD
Hydroflumethiazide—ATP1A1—hindbrain—amyotrophic lateral sclerosis	0.0188	0.0328	CbGeAlD
Hydroflumethiazide—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0589	CcSEcCtD
Hydroflumethiazide—CA4—hindbrain—amyotrophic lateral sclerosis	0.0174	0.0303	CbGeAlD
Hydroflumethiazide—KCNMA1—brainstem—amyotrophic lateral sclerosis	0.0168	0.0293	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0518	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.015	0.0481	CcSEcCtD
Hydroflumethiazide—CA2—hindbrain—amyotrophic lateral sclerosis	0.0144	0.0252	CbGeAlD
Hydroflumethiazide—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.0144	0.0251	CbGeAlD
Hydroflumethiazide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.014	0.0448	CcSEcCtD
Hydroflumethiazide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0426	CcSEcCtD
Hydroflumethiazide—CA14—spinal cord—amyotrophic lateral sclerosis	0.0128	0.0224	CbGeAlD
Hydroflumethiazide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0408	CcSEcCtD
Hydroflumethiazide—CA7—cerebellum—amyotrophic lateral sclerosis	0.0122	0.0213	CbGeAlD
Hydroflumethiazide—ATP1A1—embryo—amyotrophic lateral sclerosis	0.0118	0.0205	CbGeAlD
Hydroflumethiazide—SLC12A1—spinal cord—amyotrophic lateral sclerosis	0.0115	0.0201	CbGeAlD
Hydroflumethiazide—ATP1A1—brainstem—amyotrophic lateral sclerosis	0.0108	0.0188	CbGeAlD
Hydroflumethiazide—CA9—cerebellum—amyotrophic lateral sclerosis	0.0107	0.0187	CbGeAlD
Hydroflumethiazide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0329	CcSEcCtD
Hydroflumethiazide—CA14—cerebellum—amyotrophic lateral sclerosis	0.0102	0.0178	CbGeAlD
Hydroflumethiazide—CA4—brainstem—amyotrophic lateral sclerosis	0.00995	0.0174	CbGeAlD
Hydroflumethiazide—CA7—brain—amyotrophic lateral sclerosis	0.00991	0.0173	CbGeAlD
Hydroflumethiazide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00982	0.0314	CcSEcCtD
Hydroflumethiazide—SLC12A1—nervous system—amyotrophic lateral sclerosis	0.00969	0.0169	CbGeAlD
Hydroflumethiazide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0096	0.0307	CcSEcCtD
Hydroflumethiazide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00957	0.0306	CcSEcCtD
Hydroflumethiazide—SLC12A1—central nervous system—amyotrophic lateral sclerosis	0.00933	0.0163	CbGeAlD
Hydroflumethiazide—CA2—embryo—amyotrophic lateral sclerosis	0.009	0.0157	CbGeAlD
Hydroflumethiazide—KCNMA1—nervous system—amyotrophic lateral sclerosis	0.00878	0.0154	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00854	0.0273	CcSEcCtD
Hydroflumethiazide—KCNMA1—central nervous system—amyotrophic lateral sclerosis	0.00845	0.0148	CbGeAlD
Hydroflumethiazide—CA12—nervous system—amyotrophic lateral sclerosis	0.00842	0.0147	CbGeAlD
Hydroflumethiazide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00831	0.0266	CcSEcCtD
Hydroflumethiazide—KCNMA1—cerebellum—amyotrophic lateral sclerosis	0.00826	0.0144	CbGeAlD
Hydroflumethiazide—CA14—brain—amyotrophic lateral sclerosis	0.00825	0.0144	CbGeAlD
Hydroflumethiazide—CA2—brainstem—amyotrophic lateral sclerosis	0.00825	0.0144	CbGeAlD
Hydroflumethiazide—CA12—central nervous system—amyotrophic lateral sclerosis	0.00811	0.0142	CbGeAlD
Hydroflumethiazide—CA1—spinal cord—amyotrophic lateral sclerosis	0.00792	0.0138	CbGeAlD
Hydroflumethiazide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00758	0.0243	CcSEcCtD
Hydroflumethiazide—CA5B—nervous system—amyotrophic lateral sclerosis	0.00755	0.0132	CbGeAlD
Hydroflumethiazide—ATP1A1—medulla oblongata—amyotrophic lateral sclerosis	0.00751	0.0131	CbGeAlD
Hydroflumethiazide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0239	CcSEcCtD
Hydroflumethiazide—SLC12A1—brain—amyotrophic lateral sclerosis	0.00741	0.013	CbGeAlD
Hydroflumethiazide—CA5B—central nervous system—amyotrophic lateral sclerosis	0.00727	0.0127	CbGeAlD
Hydroflumethiazide—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.00694	0.0121	CbGeAlD
Hydroflumethiazide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00693	0.0222	CcSEcCtD
Hydroflumethiazide—KCNMA1—brain—amyotrophic lateral sclerosis	0.00671	0.0117	CbGeAlD
Hydroflumethiazide—ATP1A1—spinal cord—amyotrophic lateral sclerosis	0.0067	0.0117	CbGeAlD
Hydroflumethiazide—CA1—nervous system—amyotrophic lateral sclerosis	0.00667	0.0117	CbGeAlD
Hydroflumethiazide—CA12—brain—amyotrophic lateral sclerosis	0.00644	0.0113	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0206	CcSEcCtD
Hydroflumethiazide—CA1—central nervous system—amyotrophic lateral sclerosis	0.00642	0.0112	CbGeAlD
Hydroflumethiazide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00626	0.02	CcSEcCtD
Hydroflumethiazide—CA4—spinal cord—amyotrophic lateral sclerosis	0.00619	0.0108	CbGeAlD
Hydroflumethiazide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00597	0.0191	CcSEcCtD
Hydroflumethiazide—CA5B—brain—amyotrophic lateral sclerosis	0.00577	0.0101	CbGeAlD
Hydroflumethiazide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00577	0.0184	CcSEcCtD
Hydroflumethiazide—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.00575	0.0101	CbGeAlD
Hydroflumethiazide—ATP1A1—nervous system—amyotrophic lateral sclerosis	0.00564	0.00986	CbGeAlD
Hydroflumethiazide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00555	0.0177	CcSEcCtD
Hydroflumethiazide—Rash—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0176	CcSEcCtD
Hydroflumethiazide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00549	0.0176	CcSEcCtD
Hydroflumethiazide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00546	0.0175	CcSEcCtD
Hydroflumethiazide—ATP1A1—central nervous system—amyotrophic lateral sclerosis	0.00543	0.00949	CbGeAlD
Hydroflumethiazide—ATP1A1—cerebellum—amyotrophic lateral sclerosis	0.00531	0.00928	CbGeAlD
Hydroflumethiazide—CA4—nervous system—amyotrophic lateral sclerosis	0.00521	0.00911	CbGeAlD
Hydroflumethiazide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0166	CcSEcCtD
Hydroflumethiazide—CA2—spinal cord—amyotrophic lateral sclerosis	0.00513	0.00897	CbGeAlD
Hydroflumethiazide—CA1—brain—amyotrophic lateral sclerosis	0.0051	0.00891	CbGeAlD
Hydroflumethiazide—CA4—central nervous system—amyotrophic lateral sclerosis	0.00502	0.00877	CbGeAlD
Hydroflumethiazide—CA4—cerebellum—amyotrophic lateral sclerosis	0.00491	0.00858	CbGeAlD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0048	0.0416	CbGpPWpGaD
Hydroflumethiazide—CA2—nervous system—amyotrophic lateral sclerosis	0.00432	0.00756	CbGeAlD
Hydroflumethiazide—ATP1A1—brain—amyotrophic lateral sclerosis	0.00431	0.00754	CbGeAlD
Hydroflumethiazide—CA2—central nervous system—amyotrophic lateral sclerosis	0.00416	0.00728	CbGeAlD
Hydroflumethiazide—CA2—cerebellum—amyotrophic lateral sclerosis	0.00407	0.00711	CbGeAlD
Hydroflumethiazide—CA4—brain—amyotrophic lateral sclerosis	0.00399	0.00697	CbGeAlD
Hydroflumethiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00376	0.0326	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00351	0.0304	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00345	0.0299	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00341	0.0296	CbGpPWpGaD
Hydroflumethiazide—CA2—brain—amyotrophic lateral sclerosis	0.0033	0.00578	CbGeAlD
Hydroflumethiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00319	0.0277	CbGpPWpGaD
Hydroflumethiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—amyotrophic lateral sclerosis	0.00292	0.0253	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.0029	0.0251	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00168	0.0146	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00159	0.0138	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00153	0.0133	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00152	0.0132	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00143	0.0124	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00141	0.0123	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00137	0.0118	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00132	0.0115	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00132	0.0114	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.0013	0.0112	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular response to hypoxia—VEGFA—amyotrophic lateral sclerosis	0.00129	0.0112	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00127	0.011	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00127	0.011	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00125	0.0108	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0012	0.0104	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0012	0.0104	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00116	0.0101	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00116	0.0101	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00116	0.01	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—GSR—amyotrophic lateral sclerosis	0.00109	0.00943	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VCP—amyotrophic lateral sclerosis	0.00105	0.0091	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00898	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000953	0.00827	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000953	0.00827	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000912	0.00791	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000872	0.00756	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000867	0.00752	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000867	0.00752	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000867	0.00752	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000867	0.00752	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000853	0.0074	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000848	0.00736	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000821	0.00712	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000811	0.00703	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000804	0.00697	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000804	0.00697	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000793	0.00688	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000793	0.00688	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000775	0.00672	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000775	0.00672	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000762	0.00661	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000738	0.0064	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000738	0.0064	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000735	0.00637	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000725	0.00629	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000725	0.00629	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000707	0.00613	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000693	0.00601	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000693	0.00601	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—DAO—amyotrophic lateral sclerosis	0.000689	0.00598	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000683	0.00593	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000659	0.00571	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000659	0.00571	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000659	0.00571	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000659	0.00571	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000646	0.00561	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000642	0.00557	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000641	0.00556	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000641	0.00556	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000627	0.00544	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—DAO—amyotrophic lateral sclerosis	0.000627	0.00544	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000614	0.00533	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000614	0.00533	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000593	0.00515	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000589	0.00511	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000589	0.00511	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000587	0.00509	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000587	0.00509	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000586	0.00508	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	0.000581	0.00504	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000562	0.00487	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000545	0.00473	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000539	0.00467	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000522	0.00453	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000522	0.00453	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000518	0.00449	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000518	0.00449	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000512	0.00444	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000501	0.00434	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000491	0.00426	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000491	0.00426	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSR—amyotrophic lateral sclerosis	0.000482	0.00418	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.00048	0.00416	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000475	0.00412	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000475	0.00412	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000474	0.00411	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000471	0.00408	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000463	0.00402	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000444	0.00385	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00044	0.00382	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00044	0.00382	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSR—amyotrophic lateral sclerosis	0.000439	0.0038	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000439	0.0038	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000426	0.00369	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000414	0.00359	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	0.000406	0.00352	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000397	0.00344	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000396	0.00343	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000374	0.00325	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00036	0.00312	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00036	0.00312	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000356	0.00309	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000351	0.00305	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000337	0.00292	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000334	0.00289	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000324	0.00281	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000323	0.0028	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000311	0.00269	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000298	0.00258	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000284	0.00246	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000266	0.00231	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000262	0.00227	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000255	0.00221	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.00025	0.00217	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000245	0.00212	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000242	0.0021	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000215	0.00186	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000213	0.00185	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.000196	0.0017	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000196	0.0017	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000194	0.00168	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000194	0.00168	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000179	0.00156	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000178	0.00154	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000178	0.00154	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000165	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—APOE—amyotrophic lateral sclerosis	0.000161	0.0014	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000158	0.00137	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.000148	0.00128	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APOE—amyotrophic lateral sclerosis	0.000146	0.00127	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	0.000146	0.00127	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000143	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000137	0.00119	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	0.000136	0.00118	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000131	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000131	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000126	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000121	0.00105	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—amyotrophic lateral sclerosis	0.00012	0.00104	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000116	0.001	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00011	0.000956	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	0.000108	0.000938	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.000921	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000104	0.000899	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.0001	0.00087	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.0001	0.00087	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APOE—amyotrophic lateral sclerosis	9.94e-05	0.000862	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.29e-05	0.000806	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	8.74e-05	0.000758	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.41e-05	0.000643	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.1e-05	0.000616	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.81e-05	0.000591	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.99e-05	0.000519	CbGpPWpGaD
